TITLE

OMEGA fatty acids [...]

PUB. DATE
October 2017
SOURCE
Mail on Sunday;10/8/2017, p70
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
OMEGA fatty acids are a 'safe and effective treatment' for children with ADHD, a major review of clinical trials has concluded.
ACCESSION #
125523532

 

Related Articles

  • Omega-3 treatment of childhood depression: a controlled, double-blind pilot study.  // Latitudes Online;6/30/2006, Vol. 7 Issue 3, p11 

    The article reports the finding of a study on the use of omega-3 fatty acids in treating childhood depression. The study involved 28 children with depression, between the ages of 6 and 12. For 16 weeks the children received either omega-3 treatment or a placebo. The researchers concluded omega-3...

  • Review of Omega-3 Fatty Acids for the Treatment of Attention Deficit/Hyperactivity Disorder. Brown, Jamie N.; Panosh, Nicole // Health Services Insights;2009, Issue 2, p15 

    Objective: To review the efficacy of omega-3 fatty acids in the treatment of attention deficit/hyperactivity disorder (ADHD). Data Souces: Literature was accessed via MEDLINE (1950-February 2009) and International Pharmaceutical Abstracts (1960-2009) using the medical subject heading terms...

  • Eat Your Fatty Acids and Calm Down.  // Natural Life;Sep/Oct2005, Issue 105, p25 

    Presents a study showing the contribution of nutrition to neurological disorders such as Developmental Coordination Disorder (DCD). Comparison of dietary supplementation with Omega-3 and Omega-6 fatty acids with placebo in children with DCD; Number of children included in the trial; Effect of...

  • Treatment of Dysmenorrhea with Omega-3 Fatty Acids.  // American Family Physician;9/15/1996, Vol. 54 Issue 4, p1374 

    Examines the use of omega-3 fatty acids for the treatment of dysmenorrhea. Causes of dysmenorrhea; Effectiveness of dietary supplementation with omega-3 fatty acids in relieving dysmenorrhea; Use of fish oil for dietary supplementation.

  • Enriched flaxseed oil no fish tale for dry eye, meibomitis. Gilbard, Jeffrey P. // Ophthalmology Times;4/1/2003, Vol. 28 Issue 7, p16 

    Discusses the effectiveness of omega-3 fatty acids from flaxseed oil for the treatment of dry eye condition and meibomitis. Identification of the effect of omega-6 and omega-3 fatty acids on the body; Use of flaxseed oil combined with fish oil to treat the eye disorders; Benefits of the...

  • Fish oil for concentration in ADHD. Scahill, Shane L. // Journal of Primary Health Care;Dec2013, Vol. 5 Issue 4, p337 

    The article discusses use of fish oil in improving concentration in children with Attention Deficit Hyperactivity Disorder (ADHD). "Omega-3 fatty acid supplementation for the treatment of children with attention-deficit hyperactivity disorder symptomatology: systematic review and meta-analysis,"...

  • New Omacor reduces the risk of additional heart attacks.  // Australian Journal of Pharmacy;Dec2010, Vol. 91 Issue 1087, p14 

    The article offers information on the administration of Omacor or Omega 3-acid Ethyl Esters 90, a drug used for the risk reduction of heart attacks in Australia. According to cardiologist associate professor David Colquhoun, Omacor is the first prescription-only Omega 3 preparation in Australia...

  • DYSMENORRHEA. D'Souza, Lesley // Alive: Canada's Natural Health & Wellness Magazine;Jul2011, Issue 345, p33 

    The article discusses safe and effective natural treatments to help relieve dysmenorrhea, or menstrual pain. Impact of reducing pro-inflammatory prostaglandins (specifically PGE2) by curbing omega-6 fatty acids and increasing omega-3 fatty acids on dysmenorrhea is highlighted along with the...

  • The fats of life. Quinlivan, Beth // BRW;10/20/2005, Vol. 27 Issue 41, p78 

    Examines the effectiveness of the omega-3 fatty acids in reducing the risk of heart disease. Supplementary components of the omega-3 fatty acids; Health benefits of the omega-3 products; Prevention of hyperactivity in children and reduction of the risk of Alzheimer's disease. INSET:...

  • Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial. Janczyk, Wojciech; Socha, Piotr; Lebensztejn, Dariusz; Wierzbicka, Aldona; Mazur, Artur; Neuhoff-Murawska, Joanna; Matusik, Pawel // BMC Pediatrics;2013, Vol. 13 Issue 1, p1 

    Background: Non-alcoholic fatty liver disease (NAFLD) is a liver manifestation of metabolic syndrome since obesity and insulin resistance are the main pathogenic contributors for both conditions. NAFLD carries increased risk of atherosclerosis and cardiovascular diseases. There is an urgent need...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics